Tocagen inc (TOCA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
OPERATING ACTIVITIES
Net loss

-10,280

-10,583

-18,735

-17,114

-17,084

-19,603

-383

-16,089

-12,880

-10,837

-9,953

-9,066

-9,073

-8,430

-9,000

-8,042

-8,006

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

1,514

1,663

2,053

2,344

2,000

1,750

1,927

1,672

1,521

1,375

1,491

1,056

529

403

316

339

265

Depreciation

57

186

224

217

216

204

199

127

95

96

69

62

65

65

68

62

60

Amortization of premium (discount) on investments, net

-

-

-

-

-

-

-

-

-

-

-7

14

-1

-

0

-2

-3

Loss on disposal of property and equipment

-916

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash interest expense

654

57

1,355

144

142

145

143

726

147

149

148

146

147

-

-

-

-

Noncash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

143

140

140

Change in fair value of preferred stock warrants

-

-

-

-

-

-

-

-

-

0

0

22

-59

-32

11

-27

-2

Accretion of discount on investments, net

-103

-

-

-

41

-

-

-

46

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other assets

-877

-3,113

-1,285

2,006

-110

-3,572

2,248

309

1,223

579

307

-188

-19

-219

453

-489

412

Accounts payable

-1,591

925

-208

-285

-490

-1,107

3,051

-505

-179

804

34

543

-1,077

-278

302

67

495

Accrued liabilities

353

-5,862

1,180

-1,452

-2,777

3,065

-973

2,328

-293

-157

1,482

-274

1,895

214

697

-798

1,434

Deferred license revenue

-

-9

-9

-9

-9

-9

-1,009

991

-9

-

-

-

-

-

-

-

-

Other

328

-34

48

-19

251

174

266

336

159

-

-

-

-

-

-

-

-

Deferred license revenue

-

-

-

-

-

-

-

-

-

-

-10

-10

-11

-

-11

-13

-14

Deferred grant funding

-

-

-

-

-

-

-

-

-

-

-2

-6

-3

-11

-12

-4

-30

Net cash used in operating activities

-7,069

-10,712

-12,683

-18,161

-17,682

-11,943

945

-10,763

-12,708

-

-

-

-

-

-

-

-

INVESTING ACTIVITIES
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-7,567

-

-7,939

-7,785

-6,067

Proceeds from the sale/maturity of marketable securities

12,722

16,835

27,691

21,111

27,836

19,338

22,732

17,367

9,087

11,074

9,602

9,496

13,553

11,432

12,066

16,264

8,333

Purchases of marketable securities

-

0

8,164

21,393

21,606

18,110

24,192

15,916

12,528

39,153

1,800

20,095

9,749

4,584

5,281

7,859

5,279

Purchases of property and equipment

-

0

171

124

133

472

619

657

220

318

228

56

53

10

351

123

41

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

0

0

0

20

-

-

-

-

Net cash provided by investing activities

12,722

17,272

19,356

-406

6,097

756

-2,079

794

-3,661

-

-

-

-

-

-

-

-

FINANCING ACTIVITIES
Principal payments on notes payable

417

-

-

-

-

0

0

1,200

1,800

1,800

1,800

1,800

1,800

-

-

-

-

Proceeds from issuance of common stock

10

1

0

302

248

334

3

295

29

460

0

6

41

0

1

6

3

Proceeds from issuance of common stock under the ATM facility, net of issuance cost

-

-

-

-

1,522

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

3,771

-

6,434

8,282

3,013

Proceeds from issuance of convertible promissory notes, net of issuance costs

-

-

-

-

-

-

-

-

-

0

0

0

7,338

-

-

-

-

Cash paid for deferred equity issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

338

-

-

-

-

Net cash (used in) provided by financing activities

-407

-23,154

9

6,467

1,770

28,518

3

16,789

-1,771

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

5,246

-

-

-

-9,815

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for deferred debt and equity issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

271

29

296

Net cash (used in) provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

5,241

-

-

-23

-293

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

6,820

-18,140

-

-1,264

69,151

1,445

1,422

-1,189

474

-3,347

Cash paid for interest

-

-

-

-

-

-

-

-

214

-

-

-

-

-

-

-

-

NONCASH INVESTING AND FINANCING ACTIVITIES
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest

101

434

625

625

606

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment purchases included in accounts payable and accrued liabilities

-

-

0

11

26

-328

-227

688

45

-50

3

131

27

1

-328

246

109

Deferred equity issuance costs in accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

1,013

-

-

-

-

Deferred debt and equity issuance costs in accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

233

-244

258